General Updates

04th November, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited., National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir, Sub.: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has received an intimation dated 2nd November 2026 from KFin Technologies Limited, the Registrar to an Issue and Share Transfer Agent (“RTA”) of the Company that its Corporate Office will be shifting from its existing premises to a new location with effect from 1st December 2026. Please note that the Registered Office of the RTA shall remain unchanged. The details of the RTA’s Corporate Office are as under: Existing Corporate Office Address New Corporate Office Address: (effective from 01st December 2026) KFin Technologies Limited KFin Technologies Limited, Selenium Tower B, Plot No. 31 & 32 6th, 23rd, 24th, 25th Floor, South Tower, Gachibowli, Financial District, Rajapushpa West Avenue, Survey No. 115, Nanakramguda, Serilingampally, Hyderabad Kokapet, Serilingampally Mandal, Ranga - 500032, Telangana Reddy District, Hyderabad – 500075, Telangana With effect from 1st December 2026, all future correspondence, communications, notices and documents for the Corporate Office of the RTA should be sent to the new Corporate Office address given above. Investors and other stakeholders of the Company are requested to note the above change and update their records accordingly. Kindly take note of the above. Thanking you, Email – investorservices@torrentpharma.com Yours Sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com